What is the normal range for follicle‑stimulating hormone (FSH) during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

FSH is Suppressed During Pregnancy and Not Routinely Measured

Follicle-stimulating hormone (FSH) is physiologically suppressed to very low or undetectable levels throughout pregnancy and is not part of standard prenatal hormone monitoring. Unlike thyroid-stimulating hormone (TSH), which has well-established trimester-specific reference ranges for pregnancy management, FSH does not have clinically relevant normal ranges during gestation because it plays no active role in pregnancy maintenance.

Physiological Suppression During Pregnancy

During pregnancy, the hypothalamic-pituitary-gonadal axis is profoundly suppressed by the high circulating levels of estrogen, progesterone, and human chorionic gonadotropin (hCG). Research demonstrates that:

  • FSH levels drop dramatically from early pregnancy onward 1, 2, 3
  • Immunoreactive FSH remains suppressed from early pregnancy through term, with levels as low as 0.1-0.2 ng/mL compared to normal cycling values 2
  • This suppression begins within the first 2 weeks of gestation and continues throughout all trimesters 3
  • The suppression is maintained by elevated progesterone levels in the presence of appropriate estradiol concentrations 3

Why FSH Is Not Clinically Measured in Pregnancy

The provided guidelines extensively discuss thyroid function testing during pregnancy 4, 5, 4, 5, hyperthyroidism management 6, 7, 8, and thyroid nodule evaluation 9, but none recommend FSH measurement during pregnancy. This absence is deliberate—FSH has no diagnostic or monitoring role in prenatal care.

Key Clinical Points:

  • FSH testing is irrelevant for pregnancy management because ovarian follicular development is suspended during gestation
  • The hormone remains suppressed regardless of pregnancy complications or outcomes
  • No pregnancy-specific reference ranges exist because there is no clinical indication for measurement
  • FSH only becomes relevant again postpartum when the hypothalamic-pituitary-gonadal axis recovers

Postpartum Recovery

After delivery, FSH levels gradually return toward normal non-pregnant ranges as the suppressive effects of pregnancy hormones dissipate, though the timeline varies depending on breastfeeding status and individual hormonal recovery.

In summary: FSH has no established "normal range" during pregnancy because it is appropriately suppressed throughout gestation and serves no clinical monitoring purpose in prenatal care.

References

Research

Serum bioactive follicle-stimulating hormone-like activity increases during pregnancy.

The Journal of clinical endocrinology and metabolism, 1989

Guideline

clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2012

Guideline

graves' disease and pregnancy.

Annales d'endocrinologie, 2018

Guideline

hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and american association of clinical endocrinologists.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.